Related Experiment Video
Updated: Jun 23, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Managing diabetic dyslipidemia: aggressive approach.
1University of Pennsylvania School ofMedicine, Philadelphia, PA, USA. kelly.spratt@uphs.upenn.edu
The Journal of the American Osteopathic Association
|May 20, 2009
Summary
Obesity is increasing diabetes mellitus and metabolic syndrome rates in the US, raising coronary artery disease risk. Aggressive management of diabetic dyslipidemia, using lifestyle changes and medications, is crucial for lipid profile control.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Disorders
Background:
- Rising rates of obesity in the United States are linked to increased prevalence of diabetes mellitus and metabolic syndrome.
- These conditions significantly elevate the risk of developing coronary artery disease due to exponentially increasing risk factors.
Purpose of the Study:
- To define diabetic dyslipidemia.
- To establish the rationale for aggressive treatment of diabetic dyslipidemia.
- To outline management options for diabetic dyslipidemia, including nonpharmacologic and pharmacologic therapies.
Main Methods:
- Review of current medical literature on diabetic dyslipidemia.
- Analysis of risk factors associated with obesity, diabetes, and metabolic syndrome.
- Evaluation of treatment guidelines for lipid management in diabetic patients.
Main Results:
- Diabetic dyslipidemia is characterized by specific lipid abnormalities in diabetic patients.
- Aggressive treatment is warranted due to the high risk of cardiovascular events.
- Management strategies involve lifestyle modifications and a combination of lipid-lowering medications.
Conclusions:
- Effective management of diabetic dyslipidemia is essential for mitigating cardiovascular risk in diabetic patients.
- A multifaceted approach combining lifestyle changes and pharmacotherapy is recommended.
- Ongoing monitoring and adjustment of treatment plans are necessary for optimal lipid profile control.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:23Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...